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We thank López-Campos and colleagues for their interest in
our paper.1 As they state, we used the grip strength cut-
points from the FNIH Sarcopenia Project of <16 kg in women
and <26 kg in men, which were derived by pooling data from
nine large cohort studies.2 In sensitivity analysis, we applied
the cut-points of <20 kg in women and <30 kg in men as de-
veloped using data from the InCHIANTI study3 and subse-
quently included in the EWGSOP consensus paper.4 We
found that this led to an additional 21 participants being clas-
sified as having sarcopenia at baseline: using these cut-points
would therefore increase the prevalence of sarcopenia in our
sample from 21% to 24%. We agree with López-Campos and
colleagues that there is a need to consider cut-points for grip
strength in specific regions such as Latin America.5
Incident sarcopenia was not a rare outcome in our study,
affecting 10.9% of those at risk (33 of 302 participants). We
therefore acknowledge that the use of logistic regression
could have led to the associations between predictors such
as low BMI and incident sarcopenia being overestimated.
However, when we repeated our incident sarcopenia analy-
ses using Poisson regression, the results were similar to those
shown in Table 2 of our paper.6 For example, we found that
those with BMI 25 or above had a five-times lower risk of de-
veloping incident sarcopenia compared with those with BMI
below 18.5 [RR 0.2 (95% CI: 0.05, 0.82)].
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